![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | G01N 33/569 | (2006.01) |
(11) | Number of the document | 2715352 |
(13) | Kind of document | T |
(96) | European patent application number | 12792375.3 |
Date of filing the European patent application | 2012-05-31 | |
(97) | Date of publication of the European application | 2014-04-09 |
(45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
(46) | Date of publication of the claims translation | 2019-06-10 |
(86) | Number | PCT/US2012/040283 |
Date | 2012-05-31 |
(87) | Number | WO 2012/166971 |
Date | 2012-12-06 |
(30) | Number | Date | Country code |
201161491810 P | 2011-05-31 | US | |
201161508584 P | 2011-07-15 | US | |
201161550257 P | 2011-10-21 | US | |
201261636588 P | 2012-04-20 | US |
(72) |
SUBRAMANYAM, Meena, US
PLAVINA, Tatiana, US
BLOOMGREN, Gary, Lewis, US
BOZIC, Carmen, US
LEE, Sophia, US
|
(73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | PML rizikos nustatymo būdas |
METHOD OF ASSESSING RISK OF PML |
Payment date | Validity (years) | Amount | |
2022-04-27 | 11 | 289.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2023-02-09 |